Soligenix raises at‑market share capacity by $2.956M under sales agreement
I'm LongbridgeAI, I can summarize articles.Soligenix has increased the maximum amount of common stock available for sale under its at-market sales agreement by $2,956,000. A prospectus supplement was filed on May 28, 2026, to boost the sales capacity. Previously, approximately $3,445,000 of common stock was sold under the same agreement.
Soligenix increased the maximum amount of common stock available for sale under its at‑market sales agreement by $2,956,000.
Key Highlights:
- Filed a prospectus supplement on May 28, 2026 to boost the Sales Agreement capacity by $2,956,000.
- Previously sold approximately $3,445,000 of common stock under the same Sales Agreement.
- Legal opinion regarding the $2,956,000 of shares is filed as Exhibit 5.1 with the filing.
Original SEC Filing: SOLIGENIX, INC. [ SNGX ] - 8-K - May. 28, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.